Skip to main content

Articles

Page 37 of 82

  1. Significant progress has been made in cell replacement therapy for neural retinal diseases using retinal cells differentiated from human pluripotent stem cells. Low tumorigenicity and the ability to mature to ...

    Authors: Deng Pan, Xi-Xi Xia, Heng Zhou, Si-Qian Jin, Yang-Yan Lu, Hui Liu, Mei-Ling Gao and Zi-Bing Jin
    Citation: Stem Cell Research & Therapy 2020 11:366
  2. Transfer RNA-derived small RNAs (tsRNAs) are a recently discovered form of non-coding RNA capable of regulating myriad physiological processes. The role of tsRNAs in hMSC adipogenic differentiation, however, r...

    Authors: Tao Wang, Jun Mei, Xingnuan Li, Xiaoyuan Xu, Baicheng Ma and Weidong Li
    Citation: Stem Cell Research & Therapy 2020 11:365
  3. Bone regeneration is preferred for bone loss caused by tumors, bone defects, fractures, etc. Recently, mesenchymal stem cells are considered as optimistic tools for bone defect therapy. Dental pulp stem cells ...

    Authors: Xingyun Ge, Zehan Li, Zhou Zhou, Yibo Xia, Minxia Bian and Jinhua Yu
    Citation: Stem Cell Research & Therapy 2020 11:364
  4. Chronic low back pain is a prevalent disability, often caused by intervertebral disc (IVD) degeneration. Mesenchymal stem cell (MSC) therapy could be a safe and feasible option for repairing the degenerated di...

    Authors: Manjunatha S. Muttigi, Byoung Ju Kim, Hemant Kumar, Sunghyun Park, Un Yong Choi, Inbo Han, Hansoo Park and Soo-Hong Lee
    Citation: Stem Cell Research & Therapy 2020 11:363
  5. Peritoneal fibrosis is a serious complication of long-term peritoneal dialysis (PD). Combination therapies are emerging as a promising treatment for tissue damage. Here, we investigated the therapeutic potenti...

    Authors: Yanhong Guo, Liuwei Wang, Rong Gou, Yulin Wang, Xiujie Shi, Xinxin Pang and Lin Tang
    Citation: Stem Cell Research & Therapy 2020 11:362
  6. COVID-19 is a highly infectious respiratory disease. No therapeutics have yet been proven effective for treating severe COVID-19.

    Authors: Lei Shu, Changming Niu, Ruyou Li, Tingrong Huang, Yan Wang, Mao Huang, Ningfei Ji, You Zheng, Xiaolin Chen, Lei Shi, Mingjing Wu, Kaili Deng, Jing Wei, Xueli Wang, Yang Cao, Jiaxin Yan…
    Citation: Stem Cell Research & Therapy 2020 11:361
  7. The development of new treatment strategies to improve peripheral nerve repair after injury, especially those that accelerate axonal nerve regeneration, is very important. The aim of this study is to elucidate...

    Authors: Jiuhong Zhao, Yali Ding, Rui He, Kui Huang, Lu Liu, Chaona Jiang, Zhuozhou Liu, Yuanlan Wang, Xiaokai Yan, Fuyang Cao, Xueying Huang, Yanan Peng, Rui Ren, Yuebin He, Tianwei Cui, Quanpeng Zhang…
    Citation: Stem Cell Research & Therapy 2020 11:360
  8. Mesenchymal stem cells (MSCs) have been widely used for stem cell therapy, and serial passage of stem cells is often required to obtain sufficient cell numbers for practical applications in regenerative medici...

    Authors: Da Hyeon Choi, Se-Young Oh, Ju Kwang Choi, Kyeong Eun Lee, Ju Yeon Lee, Yoon Jeong Park, Inho Jo and Yoon Shin Park
    Citation: Stem Cell Research & Therapy 2020 11:359
  9. Although cord blood (CB) offers promise for treatment of patients with high-risk hematological malignancies and immune disorders, the limited numbers of hematopoietic stem cell (HSC)/progenitor cell in a CB un...

    Authors: Huilin Li, Haiyun Pei, Sihan Wang, Bowen Zhang, Zeng Fan, Yiming Liu, Xiaoyan Xie, Zhou Yang, Lei Xu, Yali Jia, Yun Bai, Yi Han, Lin Chen, Lijuan He, Xue Nan, Wen Yue…
    Citation: Stem Cell Research & Therapy 2020 11:358
  10. Mesenchymal stromal cells (MSCs) are rapidly advancing as commercial therapeutics. However, there are still no adequate tools to validate the identity of MSCs and support standardization of MSC-based products....

    Authors: Danielle M. Wiese and Lorena R. Braid
    Citation: Stem Cell Research & Therapy 2020 11:357
  11. Extensive passage of adipose-derived stem cells (ASCs) in vitro leads to loss of function. Endothelial colony-forming cells (ECFCs) can be isolated from adult peripheral blood. A 3D co-culture system may rescu...

    Authors: Wansheng Hu, Shengqian Zhu, Mimi Lalrimawii Fanai, Jing Wang, Junrong Cai and Jingwei Feng
    Citation: Stem Cell Research & Therapy 2020 11:355
  12. Deep venous thrombosis (DVT) constitutes a major global disease burden. Endothelial progenitor cells (EPCs) have been described in association with recanalization of venous thrombus. Furthermore, emerging evid...

    Authors: Xiaolong Du, Nan Hu, Huiying Yu, Lei Hong, Feng Ran, Dian Huang, Min Zhou, Chenglong Li and Xiaoqiang Li
    Citation: Stem Cell Research & Therapy 2020 11:354
  13. The aim of the study was to investigate annual structural and functional results, and their correlation with inheritance pattern of retinitis pigmentosa (RP) patients who were treated with Wharton’s jelly-deri...

    Authors: Emin Özmert and Umut Arslan
    Citation: Stem Cell Research & Therapy 2020 11:353
  14. The renal endothelium is a prime target for ischemia-reperfusion injury (IRI) during donation and transplantation procedures. Mesenchymal stromal cells (MSC) have been shown to ameliorate kidney function after...

    Authors: Jesus M. Sierra-Parraga, Ana Merino, Marco Eijken, Henri Leuvenink, Rutger Ploeg, Bjarne K. Møller, Bente Jespersen, Carla C. Baan and Martin J. Hoogduijn
    Citation: Stem Cell Research & Therapy 2020 11:352
  15. Mesenchymal stem cell (MSC)-derived exosomes emerge as promising candidates for treating delayed wound healing in diabetes due to the promotion of angiogenesis. Preconditioned MSC with chemical or biological f...

    Authors: Muyu Yu, Wei Liu, Junxian Li, Junxi Lu, Huijuan Lu, Weiping Jia and Fang Liu
    Citation: Stem Cell Research & Therapy 2020 11:350
  16. The biological role of miR-203 and the underlying mechanisms on the proliferation of epidermal stem cells (ESCs) have not yet been reported during the progression of chronic wound healing in diabetes mellitus....

    Authors: Jian Liu, Bin Shu, Ziheng Zhou, Yingbin Xu, Yiling Liu, Peng Wang, Kun Xiong and Julin Xie
    Citation: Stem Cell Research & Therapy 2020 11:348
  17. Significant developments in stem cell therapy for Parkinson’s disease (PD) have already been achieved; however, methods for reliable assessment of dopamine neuron maturation in vivo are lacking. Establishing t...

    Authors: Julian L. Goggi, Lifeng Qiu, Mei Chih Liao, Shivashankar Khanapur, Lingfan Jiang, Ramasamy Boominathan, Siddesh V. Hartimath, Peter Cheng, Fui Fong Yong, Vanessa Soh, Xiaozhou Deng, Youshan Melissa Lin, Anna Haslop, Peng Wen Tan, Xiaoxia Zeng, Jolene W. L. Lee…
    Citation: Stem Cell Research & Therapy 2020 11:347
  18. Research into the pathogenesis of endometriosis (EMs) would substantially promote its effective treatment and early diagnosis. However, the aetiology of EMs is poorly understood and controversial despite the p...

    Authors: Yanli Liu, Shengying Liang, Fen Yang, Yuliang Sun, Lidan Niu, Yakun Ren, Hongmei Wang, Yanan He, Jiang Du, Jun Yang and Juntang Lin
    Citation: Stem Cell Research & Therapy 2020 11:346
  19. Mesenchymal stromal cells (MSCs) are a subset of heterogeneous non-hematopoietic fibroblast-like cells that can differentiate into cells of multiple lineages, such as chondrocytes, osteoblasts, adipocytes, myo...

    Authors: Xiaomo Wu, Ju Jiang, Zhongkai Gu, Jinyan Zhang, Yang Chen and Xiaolong Liu
    Citation: Stem Cell Research & Therapy 2020 11:345
  20. Full-thickness wounds severely affect patients’ life quality and become challenging problems for clinicians. Stem cells have great prospects in the treatment of wounds. Our previous study confirmed that autolo...

    Authors: Shaobin Huang, Zhicheng Hu, Peng Wang, Yi Zhang, Xiaoling Cao, Yunxian Dong, Pu Cheng, Hailin Xu, Wenkai Zhu, Bing Tang and Jiayuan Zhu
    Citation: Stem Cell Research & Therapy 2020 11:344
  21. Inadequate vascularization is a challenge in bone tissue engineering because internal cells are prone to necrosis due to a lack of nutrient supply. Rat bone marrow-derived mesenchymal stem cells (rBMSCs) and h...

    Authors: Miaomiao Chai, Ce Gu, Qihua Shen, Jiaxing Liu, Yi Zhou, Ziyang Jin, Wanli Xiong, Yan Zhou and Wensong Tan
    Citation: Stem Cell Research & Therapy 2020 11:343
  22. Differentiation of mouse trophoblast stem cells (TSCs) to trophoblast giant cells (TGCs) has been widely used as a model system to study placental development and function. While several differentially express...

    Authors: Rahim Ullah, Ambreen Naz, Hafiza Sara Akram, Zakir Ullah, Muhammad Tariq, Aziz Mithani and Amir Faisal
    Citation: Stem Cell Research & Therapy 2020 11:342
  23. The skeletal muscle regeneration relays on the satellite cells which are stem cells located between basal lamina and plasmalemma of muscle fiber. In the injured muscles, the satellite cells become activated, s...

    Authors: Bartosz Mierzejewski, Iwona Grabowska, Daniel Jackowski, Aliksandra Irhashava, Zuzanna Michalska, Władysława Stremińska, Katarzyna Jańczyk-Ilach, Maria Anna Ciemerych and Edyta Brzoska
    Citation: Stem Cell Research & Therapy 2020 11:341
  24. In the clinical study by Le Thi Bich et al., allogeneic expanded umbilical cord-derived mesenchymal stem cells (UC-MSCs) were intravenously infused to treat patients with chronic obstructive pulmonary disease ...

    Authors: Talita Stessuk and João Tadeu Ribeiro-Paes
    Citation: Stem Cell Research & Therapy 2020 11:340

    The original article was published in Stem Cell Research & Therapy 2020 11:60

  25. It has been reported that the high-dosage administration of domestically approved pharmaceutical drugs, especially granulocyte colony-stimulating factor (G-CSF) and romiplostim (RP), is a rapid and appropriate...

    Authors: Masaru Yamaguchi, Marino Suzuki, Moeri Funaba, Akane Chiba and Ikuo Kashiwakura
    Citation: Stem Cell Research & Therapy 2020 11:339
  26. The repair of critical-sized bone defect represents a challenging problem in bone tissue engineering. To address the most important problem in bone defect repair, namely insufficient blood supply, this study a...

    Authors: Yuanjia He, Shuang Lin, Qiang Ao and Xiaoning He
    Citation: Stem Cell Research & Therapy 2020 11:338
  27. Selected placental mesenchymal stromal cells isolated from the fetal mesenchymal placental tissues (f-hPSCs) were tested as cell therapy of lethal acute radiation syndrome (ARS) with bone marrow regeneration a...

    Authors: Evgenia Volinsky, Astar Lazmi-Hailu, Nerel Cohen, Boaz Adani, Mohammad Faroja, Myriam Grunewald and Raphael Gorodetsky
    Citation: Stem Cell Research & Therapy 2020 11:337
  28. Diabetic nephropathy (DN) is one of the most serious complications of diabetes and the leading cause of end-stage chronic kidney disease. Currently, there are no effective drugs for treating DN. Therefore, nov...

    Authors: E Xiang, Bing Han, Quan Zhang, Wei Rao, Zhangfan Wang, Cheng Chang, Yaqi Zhang, Chengshu Tu, Changyong Li and Dongcheng Wu
    Citation: Stem Cell Research & Therapy 2020 11:336
  29. Mesenchymal stem cells, including those derived from human adipose tissue (hASCs), are currently being widely investigated for cell therapy. However, when transplanted at the site of injury, the survival and e...

    Authors: Patricia Garrido-Pascual, Ana Alonso-Varona, Begoña Castro, María Burón and Teodoro Palomares
    Citation: Stem Cell Research & Therapy 2020 11:335
  30. Stem cells, including induced pluripotent stem cells (iPSCs), have tremendous potential in health care, though with several significant limitations. Each of the limitations, including immunogenicity, may block...

    Authors: Xiaokai Wang, Meng Lu, Xiaoyu Tian, Yansong Ren, Yijun Li, Meng Xiang and Sifeng Chen
    Citation: Stem Cell Research & Therapy 2020 11:334
  31. Pulpitis is a common dental disease characterized by sustained inflammation and impaired pulp self-repair. Mesenchymal stem cell-based minimally invasive vital pulp therapy (MSC-miVPT) is a potential treatment...

    Authors: Hong Hong, Xiaochuan Chen, Kun Li, Nan Wang, Mengjie Li, Bo Yang, Xiaoqi Yu and Xi Wei
    Citation: Stem Cell Research & Therapy 2020 11:333
  32. Cell therapy using hepatocytes derived from stem cells has been regarded as a promising alternate to liver transplantation. However, the heterogeneity of these hepatocytes makes them unsuitable for therapeutic...

    Authors: Ja Sung Choi, In Sil Jeong, Young-Jin Park and Sung-Whan Kim
    Citation: Stem Cell Research & Therapy 2020 11:332
  33. Mesenchymal stem cells (MSCs) have a limited self-renewal ability, impaired multi-differentiation potential, and undetermined cell senescence during in vitro series expansion. To address this concern, we inves...

    Authors: Zeyuan Cao, Yunyi Xie, Le Yu, Yi Li and Yan Wang
    Citation: Stem Cell Research & Therapy 2020 11:329
  34. Cell-based tissue engineering represents a promising management for meniscus repair and regeneration. The present study aimed to investigate whether the injection of parathyroid hormone (PTH) (1-34) could prom...

    Authors: Wen Zhao, Tong Zou, Hao Cui, Yangou Lv, Dengke Gao, Chenmei Ruan, Xia Zhang and Yihua Zhang
    Citation: Stem Cell Research & Therapy 2020 11:328
  35. Despite the potential, bone marrow-derived mesenchymal stem cells (BMSCs) show limitations for beta (ß)-cell replacement therapy due to inefficient methods to deliver BMSCs into pancreatic lineage. In this stu...

    Authors: Nidheesh Dadheech, Abhay Srivastava, Mitul Vakani, Paresh Shrimali, Ramesh Bhonde and Sarita Gupta
    Citation: Stem Cell Research & Therapy 2020 11:327
  36. Periodontal ligament stem cells (PDLSCs) have many applications in the field of cytotherapy, tissue engineering, and regenerative medicine. However, the effect of age on the biological and immunological charac...

    Authors: Xiaoyu Li, Bowen Zhang, Hong Wang, Xiaolu Zhao, Zijie Zhang, Gang Ding and Fulan Wei
    Citation: Stem Cell Research & Therapy 2020 11:326
  37. Mesenchymal stem cells (MSCs) can regulate innate and adaptive immune systems through interacting with immune cells directly and secreting multiple soluble factors. Due to their immunosuppressive properties, M...

    Authors: Jingjing Qi, Xiaojun Tang, Wenchao Li, Weiwei Chen, Genhong Yao and Lingyun Sun
    Citation: Stem Cell Research & Therapy 2020 11:325
  38. Treating patients with end-stage diffuse coronary artery disease (EnD-CAD) unsuitable for coronary intervention remains a clinical challenge. They usually express refractory angina and have a high risk of mort...

    Authors: Pei-Hsun Sung, Hsin-Ju Chiang, Yi-Chen Li, John Y. Chiang, Chi-Hsiang Chu, Pei-Lin Shao, Fan-Yen Lee, Mel S. Lee and Hon-Kan Yip
    Citation: Stem Cell Research & Therapy 2020 11:324
  39. Extracellular vesicles (EVs) from human mesenchymal stem cells (hMSCs) are known to be mediators of intercellular communication and have been suggested as possible therapeutic agents in many diseases. Their po...

    Authors: Daphne Hingert, Karin Ekström, Jonathan Aldridge, Rosella Crescitelli and Helena Brisby
    Citation: Stem Cell Research & Therapy 2020 11:323

    The Correction to this article has been published in Stem Cell Research & Therapy 2020 11:443

  40. Burns remain a serious public health problem with high morbidity and mortality rates worldwide. Although there are various treatment options available, there is no consensus on the best treatment for severe bu...

    Authors: Yuan Li, Wei-dong Xia, Leanne Van der Merwe, Wen-tong Dai and Cai Lin
    Citation: Stem Cell Research & Therapy 2020 11:322
  41. Bone marrow stromal cells (BMSC) have promise in cartilage tissue engineering, but for their potential to be fully realised, the propensity to undergo hypertrophy must be mitigated. The literature contains div...

    Authors: Ena Music, Kathryn Futrega, James S. Palmer, Mackenzie Kinney, Bill Lott, Travis J. Klein and Michael R. Doran
    Citation: Stem Cell Research & Therapy 2020 11:321
  42. There are multiple promising treatment strategies for central nervous system trauma and disease. However, to develop clinically potent and safe treatments, models of human-specific conditions are needed to com...

    Authors: Chenhong Lin, Cinzia Calzarossa, Teresa Fernandez-Zafra, Jia Liu, Xiaofei Li, Åsa Ekblad-Nordberg, Erika Vazquez-Juarez, Simone Codeluppi, Lena Holmberg, Maria Lindskog, Per Uhlén and Elisabet Åkesson
    Citation: Stem Cell Research & Therapy 2020 11:320

    The Correction to this article has been published in Stem Cell Research & Therapy 2020 11:369

  43. Gestational diabetes (GDM) is a common complication of pregnancy. The impact of pregnancy complications on placental function suggests that extraembryonic stem cells in the placenta may also be affected during...

    Authors: Liyun Chen, Chung-Teng Wang, Nicholas R. Forsyth and Pensee Wu
    Citation: Stem Cell Research & Therapy 2020 11:319
  44. MicroRNAs (miRNAs) play a role in regulating osteogenic differentiation (OD) of mesenchymal stem cells by inhibiting mRNAs translation under cyclic strain. miR-503-3p was downregulated in OD of human adipose-d...

    Authors: Yadong Luo, Xu Ding, Huan Ji, Meng Li, Haiyang Song, Sheng Li, Chenxing Wang, Heming Wu and Hongming Du
    Citation: Stem Cell Research & Therapy 2020 11:318
  45. Upon migrating to the injured sites, bone marrow mesenchymal stem cells (BMSCs) play critical roles in the repair of bone lesion caused by chronic apical periodontitis. Emerging evidences have shown that Enteroco...

    Authors: Mingwei Li, Lifan Wei, Wei Zhou, Zhiyan He, Shujun Ran and Jingping Liang
    Citation: Stem Cell Research & Therapy 2020 11:317
  46. MSCs isolated from bone marrow (BM-MSCs) have well-established chondrogenic potential, but MSCs derived from the synovial membrane (SM-MSCs) and synovial fluid (SF-MSCs) are thought to possess superior chondro...

    Authors: Paul Neybecker, Christel Henrionnet, Elise Pape, Laurent Grossin, Didier Mainard, Laurent Galois, Damien Loeuille, Pierre Gillet and Astrid Pinzano
    Citation: Stem Cell Research & Therapy 2020 11:316

Annual Journal Metrics

  • 2022 Citation Impact
    7.5 - 2-year Impact Factor
    8.0 - 5-year Impact Factor
    1.440 - SNIP (Source Normalized Impact per Paper)
    1.498 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    211 days submission to accept (Median)

    2023 Usage 
    3,320,811 downloads
    1,402 Altmetric mentions